Bio News

Harvard Researchers Identify an IL-21 Mimetic That Induces Long-Term Remission in Pancreatic Cancer

Researchers at Harvard Medical School identified a compound that, when combined with a KRAS inhibitor, led to long-term remission in pancreatic cancer. In a mouse model of pancreatic cancer, only the leukocyte interleukin-21 mimetic 21h10 extended survival. 21h10 prompted macroph

11 days ago

Health Insurance Coverage to Expand for Four Rare and Underserved Cancer Treatments in October

Starting Oct. 1, the Ministry of Health and Welfare will expand health insurance coverage for four treatments for rare and underserved cancers. Vyloy, a treatment for unresectable, advanced or metastatic gastric cancer, reduced the risk of developing resistance by 41% compared wi

11 days ago

K-Bio Lab Hub Breaks Ground in Incheon’s Songdo; 60 Startups to Move In by 2028

The Ministry of SMEs and Startups held a groundbreaking ceremony for the K-Bio Lab Hub at Yonsei University’s International Campus in Songdo, Incheon. The facility is modeled on LabCentral, a biotech startup support organization in Boston. The ministry plans to house 60 biotech i

11 days ago

GC Cell’s CIK Cell Glioblastoma Study Published in International Journal

GC Cell said its study of CIK cell-based treatment for glioblastoma was published in an international journal. An analysis of 12 patients with recurrent glioblastoma found a median progression-free survival of 10.5 months and a median overall survival of 14.2 months. GC Cell plan

11 days ago

NVP Healthcare Reports Improvement in Menopausal Hot Flashes With Probiotic NVP-1905

NVP Healthcare presented results from a human study of probiotic NVP-1905 for improving menopausal hot flashes at the 2026 Women’s Medical Summit (WIMS) in Chicago. After 8 weeks of use among 130 women ages 45-60, the proportion whose hot flash frequency decreased by at least 60%

11 days ago

SK pharmteco to invest more than $200 million in U.S. expansion of small-molecule and peptide manufacturing

SK pharmteco will invest more than $200 million (about 268 billion won) over the next five years in U.S. infrastructure for the development and manufacturing of small-molecule drugs and peptides. The investment will fund a new development laboratory and peptide purification facil

11 days ago

Eli Lilly’s Amylin-Zepbound Combination Shows Mean Weight Loss of 23.3%

Eli Lilly said its amylin-Zepbound combination, eloratiZep (eloraTZP), produced mean weight loss of 23.3% in patients with obesity or overweight and diabetes. The highest-dose group lost a mean of 54.1 pounds (about 24.5 kg) at week 48. Based on these results, Eli Lilly plans to

11 days ago

FDA Begins Review of Roche’s Oral MS Drug Fenebrutinib

The U.S. Food and Drug Administration (FDA) has accepted Roche’s application for approval of its oral multiple sclerosis (MS) drug fenebrutinib and begun reviewing it for two forms of the disease: relapsing and primary progressive MS. Roche submitted the application based on resu

11 days ago

BMS reports liver injury and one death in pulmonary fibrosis drug trial, raising concerns about LPA1R inhibitors

Bristol Myers Squibb said it identified cases of liver injury, including one participant death due to liver injury, in the Phase 3 ALLOFT long-term safety extension study of admilparant, an investigational pulmonary fibrosis drug. In a protocol amendment submitted to an EU trial

11 days ago

Vanda succeeds in late-stage trial to expand Hetlioz’s sleep disorder indication

U.S.-based Vanda Pharmaceuticals advanced sleep onset by 42.5 minutes compared with placebo in a late-stage trial of Hetlioz for delayed sleep-wake phase disorder (DSWPD). The placebo group saw a change of just 5.4 minutes. Vanda plans to discuss the results with the U.S. Food an

11 days ago